http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Bioimpedance vector analysis (BIVA) predicts morbidity following hepatic resection for cancer
Simone FAMULARO,Matteo DONADON,Linda ROCCAMATISI,Gabriele DI LUCCA,Edoardo BACCALINI,Marco ANGRISANI,Eloisa FRANCHI,Pio CORLEONE,Guido TORZILLI,Luca GIANOTTI 한국간담췌외과학회 2022 Annals of hepato-biliary-pancreatic surgery Vol.26 No.-
Transarterial Therapies for Hepatocellular Carcinoma
Lanza, Ezio,Donadon, Matteo,Poretti, Dario,Pedicini, Vittorio,Tramarin, Marco,Roncalli, Massimo,Rhee, Hyungjin,Park, Young Nyun,Torzilli, Guido S. Karger AG 2017 Liver cancer Vol.6 No.1
<P><B><I>Background:</I></B> The treatment of hepatocellular carcinoma (HCC) is still a major health issue because of its increasing incidence and because of the complexity of its management. Transarterial embolization (TAE) and transarterial chemoembolization (TACE) are two widely used locoregional therapies in the treatment of HCC, especially for unresectable intermediate and advanced HCCs. <B><I>Summary: </I></B>The modern use of TAE and TACE opens new scenarios for the treatment of unresectable HCC and has yielded interesting results. The present work describes the role of transarterial therapies for HCC and focuses on the different Western and Eastern approaches to the study of response predictors. <B><I>Key Messages: </I></B>Recent refinements in interventional radiology techniques and in HCC patient selection have facilitated better local control of the disease. The molecular profiling of HCC to predict the response to TACE and TAE will greatly help clinicians identify the optimum therapy.</P>